Company
United StatesPublic company, NASDAQ: PGENPrecigen Inc (NASDAQ: PGEN), Germantown, MD – FDA Inspections
Inspection records and compliance data for Precigen Inc in Germantown, Maryland. 2 FDA inspections on record, last inspected May 02, 2025. Publicly traded as NASDAQ: PGEN.
Company Profile
This profile covers Precigen Inc based in Germantown, Maryland, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected April 15, 2025. Last inspected May 2, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 2, 2025 | Not classified | Biologics | 1278308 |
| April 15, 2025 | Not classified | Biologics | 1269309 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Precigen Inc
Stock ticker
PGEN
Exchange
NASDAQ
Share price
$4.66
Market cap
$1.7B
Price as of
November 13, 2026
FEI Number
3014429654
Address
20358 Seneca Meadows Pkwy, Germantown, Maryland 20876, United States
Country
United States
ID: 4e287f51-098f-4643-9b3f-0456ce72600e